tiprankstipranks
Trending News
More News >
Sinopharm Group Co Class H (HK:1099)
:1099
Hong Kong Market
Advertisement

Sinopharm Group Co (1099) Stock Forecast & Price Target

Compare
7 Followers
See the Price Targets and Ratings of:

1099 Analyst Ratings

Moderate Buy
1Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
Based on 1 analysts giving stock ratings to
Sinopharm
Group Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1099 Stock 12 Month Forecast

Average Price Target

HK$21.51
▲(11.26% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Sinopharm Group Co in the last 3 months. The average price target is HK$21.51 with a high forecast of HK$21.51 and a low forecast of HK$21.51. The average price target represents a 11.26% change from the last price of HK$19.33.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"16":"HK$16","19":"HK$19","22":"HK$22","17.5":"HK$17.5","20.5":"HK$20.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":21.5063891362,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$21.51</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21.5063891362,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$21.51</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21.5063891362,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$21.51</span>\n  </div></div>","useHTML":true}}],"tickPositions":[16,17.5,19,20.5,22],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2024","6":"Oct<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.884,18.162645318169233,18.44129063633846,18.719935954507694,18.998581272676923,19.277226590846155,19.555871909015384,19.834517227184616,20.113162545353845,20.391807863523077,20.670453181692306,20.949098499861538,21.227743818030767,{"y":21.5063891362,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.884,18.162645318169233,18.44129063633846,18.719935954507694,18.998581272676923,19.277226590846155,19.555871909015384,19.834517227184616,20.113162545353845,20.391807863523077,20.670453181692306,20.949098499861538,21.227743818030767,{"y":21.5063891362,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.884,18.162645318169233,18.44129063633846,18.719935954507694,18.998581272676923,19.277226590846155,19.555871909015384,19.834517227184616,20.113162545353845,20.391807863523077,20.670453181692306,20.949098499861538,21.227743818030767,{"y":21.5063891362,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":20.006,"date":1688169600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.006,"date":1698796800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.006,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.788,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.999,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.73,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.999,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.759,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.326,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.826,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.595,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.634,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.884,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetHK$21.51Average Price TargetHK$21.51Lowest Price TargetHK$21.51
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on HK:1099
TR | OpenAI - 4o
TR | OpenAI - 4o
HK$20.5HK$21.5
Buy
11.23%
Upside
Reiterated
06/10/25
AI Generated ArticleAI Generated Article
Nomura
HK$25.09HK$23.4
Buy
21.06%
Upside
Reiterated
03/25/25
Sinopharm Group Co Ltd. (1099:HK) (SHTDF) PT Lowered to HK$23.40 at Nomura/InstinetNomura/Instinet analyst Jialin Zhang lowered the price target on Sinopharm Group Co Ltd. (1099:HK) (OTC: SHTDF) to HK$23.40 (from HK$25.09) while maintaining a Buy rating.
DBS
HK$15HK$25
Buy
29.33%
Upside
Upgraded
12/12/24
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (NASDAQ: BLFS) and Sinopharm Group Co (Other OTC: SHTDF)
Jefferies Analyst forecast on HK:1099
Unknown Analyst
Jefferies
Not Ranked
Jefferies
HK$21.4
Hold
10.71%
Upside
Downgraded
10/25/24
Morgan Stanley Analyst forecast on HK:1099
Morgan Stanley
Morgan Stanley
HK$27HK$25
Buy
29.33%
Upside
Reiterated
08/26/24
Sinopharm Group Co Ltd. (1099:HK) (SHTDF) PT Lowered to HK$25 at Morgan StanleyMorgan Stanley analyst Laurence Tam lowered the price target on Sinopharm Group Co Ltd. (1099:HK) (OTC: SHTDF) to HK$25.00 (from HK$27.00) while maintaining a Overweight rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on HK:1099
TR | OpenAI - 4o
TR | OpenAI - 4o
HK$20.5HK$21.5
Buy
11.23%
Upside
Reiterated
06/10/25
AI Generated ArticleAI Generated Article
Nomura
HK$25.09HK$23.4
Buy
21.06%
Upside
Reiterated
03/25/25
Sinopharm Group Co Ltd. (1099:HK) (SHTDF) PT Lowered to HK$23.40 at Nomura/InstinetNomura/Instinet analyst Jialin Zhang lowered the price target on Sinopharm Group Co Ltd. (1099:HK) (OTC: SHTDF) to HK$23.40 (from HK$25.09) while maintaining a Buy rating.
DBS
HK$15HK$25
Buy
29.33%
Upside
Upgraded
12/12/24
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (NASDAQ: BLFS) and Sinopharm Group Co (Other OTC: SHTDF)
Jefferies Analyst forecast on HK:1099
Unknown Analyst
Jefferies
Not Ranked
Jefferies
HK$21.4
Hold
10.71%
Upside
Downgraded
10/25/24
Morgan Stanley Analyst forecast on HK:1099
Morgan Stanley
Morgan Stanley
HK$27HK$25
Buy
29.33%
Upside
Reiterated
08/26/24
Sinopharm Group Co Ltd. (1099:HK) (SHTDF) PT Lowered to HK$25 at Morgan StanleyMorgan Stanley analyst Laurence Tam lowered the price target on Sinopharm Group Co Ltd. (1099:HK) (OTC: SHTDF) to HK$25.00 (from HK$27.00) while maintaining a Overweight rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sinopharm Group Co

1 Month
xxx
Success Rate
2/7 ratings generated profit
29%
Average Return
-1.46%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 28.57% of your transactions generating a profit, with an average return of -1.46% per trade.
3 Months
xxx
Success Rate
3/7 ratings generated profit
43%
Average Return
-4.67%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of -4.67% per trade.
1 Year
Success Rate
2/7 ratings generated profit
29%
Average Return
-6.21%
reiterated a buy rating 5 months ago
Copying Jialin Zhang's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -6.21% per trade.
2 Years
xxx
Success Rate
2/7 ratings generated profit
29%
Average Return
-5.56%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 28.57% of your transactions generating a profit, with an average return of -5.56% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1099 Analyst Recommendation Trends

Rating
Feb 25
Mar 25
Apr 25
May 25
Jun 25
Strong Buy
3
3
2
3
7
Buy
0
0
0
0
0
Hold
1
0
2
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
3
4
5
9
In the current month, 1099 has received 7 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. 1099 average Analyst price target in the past 3 months is 21.51.
Each month's total comprises the sum of three months' worth of ratings.

1099 Financial Forecast

1099 Earnings Forecast

Next quarter’s earnings estimate for 1099 is HK$1.06 with a range of HK$1.06 to HK$1.06. The previous quarter’s EPS was HK$0.51. 1099 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.35% of the time in the same period. In the last calendar year 1099 has Preformed in-line its overall industry.
Next quarter’s earnings estimate for 1099 is HK$1.06 with a range of HK$1.06 to HK$1.06. The previous quarter’s EPS was HK$0.51. 1099 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.35% of the time in the same period. In the last calendar year 1099 has Preformed in-line its overall industry.

1099 Sales Forecast

Next quarter’s sales forecast for 1099 is HK$317.74B with a range of HK$317.74B to HK$317.74B. The previous quarter’s sales results were ―. 1099 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.82% of the time in the same period. In the last calendar year 1099 has Preformed in-line its overall industry.
Next quarter’s sales forecast for 1099 is HK$317.74B with a range of HK$317.74B to HK$317.74B. The previous quarter’s sales results were ―. 1099 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.82% of the time in the same period. In the last calendar year 1099 has Preformed in-line its overall industry.

1099 Stock Forecast FAQ

What is HK:1099’s average 12-month price target, according to analysts?
Based on analyst ratings, Sinopharm Group Co Class H’s 12-month average price target is 21.51.
    What is HK:1099’s upside potential, based on the analysts’ average price target?
    Sinopharm Group Co Class H has 11.26% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Sinopharm Group Co Class H a Buy, Sell or Hold?
          Sinopharm Group Co Class H has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Sinopharm Group Co Class H’s share price target?
            The average share price target for Sinopharm Group Co Class H is 21.51. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is HK$21.51 ,and the lowest forecast is HK$21.51. The average share price target represents 11.26% Increase from the current price of HK$19.33.
              What do analysts say about Sinopharm Group Co Class H?
              Sinopharm Group Co Class H’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
                How can I buy shares of Sinopharm Group Co Class H?
                To buy shares of HK:1099, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis